Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,719
archived clinical trials in
Diabetic Neuropathy

Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated:  8/29/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Diabetic Neuropathy
A Multicenter Randomized, Double-Blind, Placebo-Controlled, 2-Arm Parallel-Group Study to Determine the Efficacy and Safety of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Pain Associated With Painful Diabetic Neuropathy
Status: Enrolling
Updated: 8/29/2017
Clinical Research Facility
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Innovative Research of West Florida, Inc.
mi
from
Clearwater, FL
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
Creighton University Medical Center
mi
from
Omaha, NE
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Southeast Renal Research Institute
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
TAD Clinical Research
mi
from
Lufkin, TX
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
TAD Clinical Research
mi
from
Lufkin, TX
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
Renal Associates, PA
mi
from
San Antonio, TX
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
Renal Associates, PA
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated:  9/7/2017
mi
from
Sofia,
Study of LY3016859 in Participants With Diabetic Nephropathy
Study of the Safety and Efficacy of LY3016859 After Multiple Intravenous Dosing in Diabetic Nephropathy Patients
Status: Enrolling
Updated: 9/7/2017
mi
from
Sofia,
Click here to add this to my saved trials
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen.
Status: Enrolling
Updated:  10/4/2017
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Randomized Open Label Study Comparing the Metabolic Control of Kidney Transplant Recipients With Type 2 Diabetes Receiving Either Prograf or Neoral as Part of a ATG Induction, Prednisone Free and Monitored MMF Immunosuppressive Regimen.
Status: Enrolling
Updated: 10/4/2017
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
ILD Research Center
mi
from
Carlsbad, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
ILD Research Center
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Spartanburg Regional Healthcare System
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
North Texas Podiatric Medicine and Surgery Associates
mi
from
Dallas, TX
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
North Texas Podiatric Medicine and Surgery Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Texas Gulf Coast Medical Group
mi
from
Webster, TX
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Texas Gulf Coast Medical Group
mi
from
Webster, TX
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
SAVAHCS
mi
from
Tucson, AZ
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
SAVAHCS
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Stanford University
mi
from
Stanford, CA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
SSH
mi
from
South Weymouth, MA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
SSH
mi
from
South Weymouth, MA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
NSLIJHS
mi
from
Lake Success, NY
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
NSLIJHS
mi
from
Lake Success, NY
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
UNC
mi
from
Chapel Hill, NC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
UNC
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Duke University
mi
from
Durham, NC
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
University Orthopedics
mi
from
Altoona, PA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
University Orthopedics
mi
from
Altoona, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Temple University
mi
from
Philadelphia, PA
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
MedStar Georgetown University Hospital
mi
from
Washington, D.C.,
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
MedStar Georgetown University Hospital
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  10/5/2017
Barry University Clinical Research
mi
from
North Miami Beach, FL
Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers
A Multicenter, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Cryopreserved Human Amniotic Membrane for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 10/5/2017
Barry University Clinical Research
mi
from
North Miami Beach, FL
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kansas City, MO
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Inglewood, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Inglewood, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Northridge, CA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Denver, CO
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Wichita, KA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Kenner, LA
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Kenner, LA
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Rockville, MD
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Omaha, NE
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Durham, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Beachwood, OH
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated:  11/17/2017
Clinical Research Facility
mi
from
Bend, OR
A Study in Participants With Diabetic Kidney Disease
A Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 2 Study to Evaluate the Safety and Renal Efficacy of LY2382770 in Patients With Diabetic Kidney Disease Due to Type 1 or Type 2 Diabetes
Status: Enrolling
Updated: 11/17/2017
Clinical Research Facility
mi
from
Bend, OR
Click here to add this to my saved trials